Clinical Study
Pathologies Associated with Serum IgG4 Elevation
Table 2
Final diagnosis in patients with elevated serum IgG4 level (>1.35 g/L).
| | (%) | Mean IgG4 levels (g/L)
| (extremes) |
| Repeated infections | 15 (25.4%) | 2.31 (1.37–4.3) | Autoimmune diseases | 8 (13.6%) | 3.62 (1.38–11.3) | No final diagnosis | 8 (13.6%) | 1.94 (1.37–2.97) | IgG4-RD | 6 (10.1%) | 12.64 (2.48−20.6) | Possible IgG4-RD | 5 (8.5%) | 2.23 (1.56–3.37) | Cancer | 4 (6.8%) | 2.00 (1.71–2.32) | Primary immune deficiency | 4 (6.8%) | 1.80 (1.44–2.24) | Interstitial pneumonitis | 3 (5%) | 5.54 (1.51–12.7) | Cystic fibrosis | 2 (3.4%) | 4.49 (3.36–5.62) | Erdheim Chester disease | 2 (3.4%) | 3.05 (2.15–3.94) | Vasculitis | 2 (3.4%) | 3.68 (3.06–4.30) |
|
|
IgG4-RD: IgG4-related disease. Apart from the final diagnostic retained, allergic and atopic manifestations were found in 10 patients (16.9%).
|